Neuroscience News

A Stanford Medicine magazine article shares four stories of digital medicine helping patients.

New study points to remarkable outcomes for victims of paralysis.

What does any part of the brain do? This simple question remains largely unanswered in cognitive neuroscience, where researchers are charting out the functional territories of the human brain.

Stanford researchers have developed an electronic glove that bestows robotic hands with some of the manual dexterity humans enjoy.

New technology could make your drive therapy time.

In a study, paralyzed people with tiny brain implants were able to directly operate a tablet just by thought.

Scope, the Stanford Medicine blog, recently profiled JOHN ADLER, a neurosurgeon and innovator whose desire to help patients has led him down an entrepreneurial path multiple times.

Capturing the brain’s learning and recall motor in silicon

The Stanford project, led by neuroscientists Tony Wyss-Coray and Marion Buckwalter, will focus on the influence of immune factors and systemic inflammation on the brain.

Why a defective gene is tied so strongly to Parkinson’s disease has baffled researchers. Now, a study led by Stanford scientists appears to have pieced together a major part of the puzzle.

Artificial intelligence has a problem: The biases of its creators are getting hard-coded into its future. Fei-Fei Li has a plan to fix that—by rebooting the field she helped invent.

Andra Blomkalns, Gerald Grant, David Kingsley and Crystal Mackall have been appointed to endowed professorships.

Genetic mutations affecting a single gene called LRRK2 play an outsized role in Parkinson's disease, but nobody's been able to say what the connection is between the genetic defect and the brain-cell die-off that characterizes the condition. Here's a clue

Studies have associated low zinc levels with autism spectrum disorder. But why this should be the case has been unclear. Now, scientists may have an explanation for the link.

Stanford researchers have shown in rats that pharmacologically active amounts of a fast-acting anesthetic drug could be released from nanoparticle "cages" in small, specified brain areas at which the scientists had aimed a beam of focused ultrasound.

Stanford researchers used focused ultrasound to pry molecules of an anesthetic loose from nanoparticles. The drug’s release modified activity in brain regions targeted by the ultrasound beam.